| Product Code: ETC8547219 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the Netherlands continued to see a steady flow of pyruvate kinase imports, with major exporters including Germany, Denmark, Finland, Belgium, and the USA. Despite the presence of these key players, market concentration, as measured by the HHI index, remained at a moderate level. The compound annual growth rate (CAGR) from 2020 to 2024 was an impressive 16.09%, indicating a strong upward trajectory for the market. Moreover, the growth rate from 2023 to 2024 surged to 26.75%, reflecting a notable acceleration in import activity within the sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Pyruvate Kinase Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Pyruvate Kinase Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Pyruvate Kinase Market - Industry Life Cycle |
3.4 Netherlands Pyruvate Kinase Market - Porter's Five Forces |
3.5 Netherlands Pyruvate Kinase Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Netherlands Pyruvate Kinase Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pyruvate kinase deficiency in the Netherlands |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of pyruvate kinase disorders |
4.2.3 Advances in research and development leading to new treatment options for pyruvate kinase deficiency |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of pyruvate kinase deficiency treatments |
4.3.2 Limited availability of specialized healthcare providers for pyruvate kinase disorders in the Netherlands |
5 Netherlands Pyruvate Kinase Market Trends |
6 Netherlands Pyruvate Kinase Market, By Types |
6.1 Netherlands Pyruvate Kinase Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Pyruvate Kinase Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Netherlands Pyruvate Kinase Market Revenues & Volume, By Pyrukynd (Mitapivat), 2021- 2031F |
6.1.4 Netherlands Pyruvate Kinase Market Revenues & Volume, By RPL301, 2021- 2031F |
7 Netherlands Pyruvate Kinase Market Import-Export Trade Statistics |
7.1 Netherlands Pyruvate Kinase Market Export to Major Countries |
7.2 Netherlands Pyruvate Kinase Market Imports from Major Countries |
8 Netherlands Pyruvate Kinase Market Key Performance Indicators |
8.1 Number of patients diagnosed with pyruvate kinase deficiency in the Netherlands |
8.2 Adoption rate of newly developed treatments for pyruvate kinase disorders |
8.3 Number of clinical trials for pyruvate kinase deficiency treatments in the Netherlands |
9 Netherlands Pyruvate Kinase Market - Opportunity Assessment |
9.1 Netherlands Pyruvate Kinase Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Netherlands Pyruvate Kinase Market - Competitive Landscape |
10.1 Netherlands Pyruvate Kinase Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Pyruvate Kinase Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |